Inventronics Future Growth
Future criteria checks 0/6
Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Inventronics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Building earnings growth | 11.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Investors Holding Back On Inventronics Limited (CVE:IVX)
Jan 04Calculating The Intrinsic Value Of Inventronics Limited (CVE:IVX)
Nov 17We Think Inventronics (CVE:IVX) Can Manage Its Debt With Ease
Jul 22These 4 Measures Indicate That Inventronics (CVE:IVX) Is Using Debt Safely
Apr 05We Discuss Whether Inventronics Limited's (CVE:IVX) CEO Is Due For A Pay Rise
Nov 03Is Now The Time To Put Inventronics (CVE:IVX) On Your Watchlist?
Oct 26These 4 Measures Indicate That Inventronics (CVE:IVX) Is Using Debt Safely
Oct 05We Ran A Stock Scan For Earnings Growth And Inventronics (CVE:IVX) Passed With Ease
Jul 28Inventronics (CVE:IVX) Has A Pretty Healthy Balance Sheet
Jun 22Inventronics (CVE:IVX) Has A Rock Solid Balance Sheet
Mar 03Should You Be Adding Inventronics (CVE:IVX) To Your Watchlist Today?
Jan 24These 4 Measures Indicate That Inventronics (CVE:IVX) Is Using Debt Safely
Dec 01Inventronics' (CVE:IVX) Earnings Are Of Questionable Quality
Oct 28Do Inventronics's (CVE:IVX) Earnings Warrant Your Attention?
Oct 14This Is The Reason Why We Think Inventronics Limited's (CVE:IVX) CEO Deserves A Bump Up To Their Compensation
Aug 12Does Inventronics (CVE:IVX) Deserve A Spot On Your Watchlist?
Jul 14Is Inventronics Limited's (CVE:IVX) 41% ROE Better Than Average?
Mar 01Is Inventronics Limited's (CVE:IVX) 41% ROE Better Than Average?
Dec 01In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Inventronics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 9 | 0 | 1 | 2 | N/A |
9/30/2023 | 11 | 1 | 1 | 3 | N/A |
6/30/2023 | 13 | 1 | 2 | 3 | N/A |
3/31/2023 | 14 | 2 | 2 | 3 | N/A |
12/31/2022 | 14 | 2 | 2 | 2 | N/A |
9/30/2022 | 13 | 2 | 2 | 2 | N/A |
6/30/2022 | 13 | 3 | 2 | 2 | N/A |
3/31/2022 | 12 | 2 | 1 | 1 | N/A |
12/31/2021 | 10 | 2 | 1 | 1 | N/A |
9/30/2021 | 9 | 2 | 1 | 1 | N/A |
6/30/2021 | 8 | 1 | 0 | 1 | N/A |
3/31/2021 | 6 | 1 | 1 | 1 | N/A |
12/31/2020 | 6 | 1 | 0 | 1 | N/A |
9/30/2020 | 6 | 1 | 0 | 1 | N/A |
6/30/2020 | 5 | 0 | 1 | 1 | N/A |
3/31/2020 | 6 | 0 | 0 | 0 | N/A |
12/31/2019 | 6 | 0 | 0 | 0 | N/A |
9/30/2019 | 6 | 1 | 0 | 0 | N/A |
6/30/2019 | 6 | 0 | 0 | 0 | N/A |
3/31/2019 | 5 | 0 | 0 | 0 | N/A |
12/31/2018 | 5 | 0 | 0 | 0 | N/A |
9/30/2018 | 4 | 0 | 0 | 0 | N/A |
6/30/2018 | 4 | 0 | 0 | 0 | N/A |
3/31/2018 | 4 | 0 | 0 | 0 | N/A |
12/31/2017 | 4 | 0 | 0 | 0 | N/A |
9/30/2017 | 4 | 0 | N/A | 0 | N/A |
6/30/2017 | 4 | 0 | N/A | 0 | N/A |
3/31/2017 | 4 | 0 | N/A | 0 | N/A |
12/31/2016 | 4 | 0 | N/A | 0 | N/A |
9/30/2016 | 4 | 0 | N/A | 0 | N/A |
6/30/2016 | 4 | 0 | N/A | 0 | N/A |
3/31/2016 | 4 | 0 | N/A | 0 | N/A |
12/31/2015 | 4 | 0 | N/A | 0 | N/A |
9/30/2015 | 4 | 0 | N/A | 0 | N/A |
6/30/2015 | 5 | 0 | N/A | 0 | N/A |
3/31/2015 | 5 | 0 | N/A | 0 | N/A |
12/31/2014 | 5 | 0 | N/A | 0 | N/A |
9/30/2014 | 5 | 0 | N/A | 0 | N/A |
6/30/2014 | 6 | 0 | N/A | 0 | N/A |
3/31/2014 | 6 | 0 | N/A | 0 | N/A |
12/31/2013 | 6 | 0 | N/A | 1 | N/A |
9/30/2013 | 5 | 0 | N/A | 1 | N/A |
6/30/2013 | 5 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Ingresos vs. tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de IVX es superior a la tasa de ahorro (1.9%).
Beneficios frente mercado: Datos insuficientes para determinar si se prevé que los beneficios de IVX crezcan más deprisa que el mercado Canadian
Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de IVX crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de IVX crezcan más rápido que el mercado de Canadian.
Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de IVX crezcan a un ritmo superior a 20% al año.
Earnings per Share Growth Forecasts
Future Return on Equity
Futura rentabilidad financiera (ROE): Datos insuficientes para determinar si la Rentabilidad de los fondos propios de IVX se prevé elevada dentro de 3 años.